retatrutide at 17 Demand for Unapproved Weight-Loss Drug Surges on Social Media RETATRUTIDE: The Game-Changing Weight Loss

Regulatory outlook Seven additional Phase 3 readouts are expected before the end of 2026

It is committed to the treatment of major diseases in the areas of oncology, anti-infections, CNS diseases, metabolic diseases, as well as autoimmune diseases, and is dedicated to improving human health through continuous innovation

Since their initial approval in the early 2000 s, the pharmacotherapy of GLP-1 RAs has been well recognized not only for achieving glycemic targets but also for their effectiveness in promoting satiety and weight loss, as well as their association with reductions in cardiovascular risk and all-cause mortality

Lost more than 35 pounds and have kept it off

Once reconstituted with bacteriostatic water, the solution remains stable for four to six weeks refrigerated

A couple liters a day of water is a good estimate